These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 16806412

  • 1. T1c prostate cancer detection rate and pathologic characteristics: comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population.
    Park HK, Hong SK, Byun SS, Lee SE.
    Urology; 2006 Jul; 68(1):85-8. PubMed ID: 16806412
    [Abstract] [Full Text] [Related]

  • 2. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ, Mangold LA, Epstein JI, Partin AW.
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [Abstract] [Full Text] [Related]

  • 3. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
    Bozeman CB, Carver BS, Caldito G, Venable DD, Eastham JA.
    Urology; 2005 Oct; 66(4):803-7. PubMed ID: 16230142
    [Abstract] [Full Text] [Related]

  • 4. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 5. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.
    Berger AP, Spranger R, Kofler K, Steiner H, Bartsch G, Horninger W.
    Prostate; 2003 Oct 01; 57(2):93-8. PubMed ID: 12949932
    [Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC, Hovey R, Carroll PR, Shinohara K.
    J Urol; 1996 Nov 01; 156(5):1685-90. PubMed ID: 8863571
    [Abstract] [Full Text] [Related]

  • 7. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK, Chung MK, Ryu SB, Lee KH, Korean Urological Oncologic Society Prostate Cancer Study Group.
    Urology; 2007 Dec 01; 70(6):1109-12. PubMed ID: 18158028
    [Abstract] [Full Text] [Related]

  • 8. [Prostate cancer detection by prostate biopsy among Japanese with prostate-specific antigen below 4.0 ng/ml].
    Kanno T, Shibasaki N, Tsuji Y, Taki Y, Takeuchi H.
    Hinyokika Kiyo; 2006 Mar 01; 52(3):181-4. PubMed ID: 16617870
    [Abstract] [Full Text] [Related]

  • 9. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
    Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, Naya Y, Ichikawa T.
    Urology; 2006 Oct 01; 68(4):815-9. PubMed ID: 17070359
    [Abstract] [Full Text] [Related]

  • 10. Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.
    Recker F, Kwiatkowski MK, Huber A, Stamm B, Lehmann K, Tscholl R.
    J Urol; 2001 Sep 01; 166(3):851-5. PubMed ID: 11490232
    [Abstract] [Full Text] [Related]

  • 11. Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis.
    Zhu H, Roehl KA, Antenor JA, Catalona WJ.
    Urology; 2005 Sep 01; 66(3):547-51. PubMed ID: 16140075
    [Abstract] [Full Text] [Related]

  • 12. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
    Yang WJ, Lee DH, Chung BH, Cho JS, Choi YD, Kim SJ, Cho IR, Kim HS, Kim CI, Hong SJ, Members of the Severance Urologic Oncology Group.
    Urology; 2006 Feb 01; 67(2):333-6. PubMed ID: 16461083
    [Abstract] [Full Text] [Related]

  • 13. Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
    Pelzer AE, Colleselli D, Bektic J, Steiner E, Ramoner R, Mitterberger M, Schwentner C, Schaefer G, Ongarello S, Bartsch G, Horninger W.
    BJU Int; 2008 Apr 01; 101(7):822-5. PubMed ID: 18261154
    [Abstract] [Full Text] [Related]

  • 14. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D, Kamil ST, Pakasi LS.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():563-70. PubMed ID: 10895211
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK.
    Cancer; 2007 Apr 15; 109(8):1689-95. PubMed ID: 17330856
    [Abstract] [Full Text] [Related]

  • 17. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience.
    Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M.
    BJU Int; 2008 Jan 15; 101(2):165-9. PubMed ID: 17850361
    [Abstract] [Full Text] [Related]

  • 18. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
    Bulbul MA, Khauli RB, Nasr R, Hemady K, Wazzan W.
    J Med Liban; 2000 Jan 15; 48(2):59-62. PubMed ID: 11028151
    [Abstract] [Full Text] [Related]

  • 19. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.
    Cancer; 2008 Jun 15; 112(12):2664-70. PubMed ID: 18433013
    [Abstract] [Full Text] [Related]

  • 20. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 01; 88(1):16-8. PubMed ID: 18346372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.